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1078–5884/00Prevalence and Prognostic Significance of Asymptomatic
Peripheral Arterial Disease in 68-year-old Men with Diabetes.
Results from the Population Study ‘Men Born in 1914’ from
Malmo¨, Sweden
M. O¨gren,* B. Hedblad, G. Engstro¨m and L. JanzonDepartment of Community Medicine, Division of Epidemiology, Lund University, Malmo¨ University
Hospital, Malmo¨, SwedenObjective. To assess the prevalence of asymptomatic peripheral arterial disease (PAD) in older men with diabetes and to
compare the incidence of cardiac events and deaths in diabetic and non-diabetic men with abnormal and normal systolic
ankle–brachial pressure index, respectively.
Research design and methods. Population-based cohort of 68-year-old men (nZ474). Diabetes was defined as history of
diabetes or a fasting blood glucoseR6.1 mmol/l. PAD was defined as an ankle–brachial pressure index (ABI)!0.9 in either
leg. Fourteen-year mortality and cardiac event rates were based on record linkage with regional and national registers.
Results. The prevalence of PAD in men with and without diabetes was 29 and 12%, respectively (pZ0.003). The incidence
of cardiac events was 22.9/1000 person years in men free from both diabetes and PAD. In the absence of an abnormal pressure
index, diabetes was associated with an event rate of 28.4 (pZ0.469). In the presence of an abnormal index the incidence was
102 (p!0.001). This pattern remained in the multivariate analysis when other atherosclerotic risk factors were taken into
account. Cardiovascular mortality rates similarly differed substantially between diabetic men with and without PAD.
Conclusions. A fasting blood glucose value above 6.1 mmol/l even in the absence of symptoms indicating diabetes was
associated by an increased prevalence of asymptomatic PAD. The cardiovascular risk in diabetes varied widely between men
with and without abnormal ankle–brachial pressure index.Keywords: Arterial occlusive disease; Non-insulin-dependent diabetes mellitus; Ankle–brachial blood pressure index;
Epidemiology; Cardiac event rate.Introduction
Diabetes is associated with an increased incidence of
myocardial infarction, stroke and peripheral arterial
disease (PAD).1–5 This risk remains when other major
cardiovascular risk factors are taken into account.
Measurement of the systolic ankle–brachial press-
ure index (ABI) is a simple method with demonstrated
validity in population settings for the detection of even
pre-symptomatic stages of atherosclerotic PAD.6–8 The
increased cardiovascular risk associated with a low
ABI has been demonstrated in several cohort studies
and reflects the generalised nature of atherosclerotic
disease.9–12 In apparently healthy subjects exposed to
risk factors associated with the occurrence ofing author. Dr Mats O¨gren, MD, PhD, Department of
Medicine, Division of Epidemiology, Lund University,
ersity Hospital, SE-205 02 Malmo¨, Sweden.
: mats.ogren@astrazeneca.com
0182 + 08 $35.00/0 q 2004 Elsevier Ltd. All rights resercardiovascular disease, measurement of the ABI can
be used as a prognostic marker to identify those who
are most vulnerable.
Whether non-invasively detected PAD is a similar
prognostic marker in diabetes has not been evaluated in
population-based studies. Since diabetes is associated
with vascular manifestations apart from atherosclerotic
disease, so called ‘small vessel disease’,13 this cannot be
readily assumed. The aim of this study was to evaluate
the prognostic significance of a low ankle–brachial index
in relation to diabetes in 68-year-old men.Materials and MethodsStudy population
The cohort study ‘Men born in 1914’, Malmo¨,
Sweden, was designed to identify determinants forEur J Vasc Endovasc Surg 29, 182–189 (2005)
doi:10.1016/j.ejvs.2004.11.013, available online at http://www.sciencedirect.com onved.
Asymptomatic PAD in Diabetes 183cardiovascular and pulmonary diseases in elderly
men.14 All men born in even months in 1914 and
residing in the city were in 1982–1983, close to their
68th birthday, invited to a health examination. Of 621
invited 474 (76.4%) took part in the assessment of
diabetes and peripheral arterial disease.Diabetes mellitus
Blood samples for determination of blood glucose
were drawn after a minimum fasting period of 8 h.
Diabetes mellitus, defined as either a history of
diabetes mellitus at the health examination, or a
fasting blood (fB) glucose R6.1 mmol/l15 was found
in 48 (10.1%) of the 474 men. Twenty men had a history
of diabetes; of these, two received insulin treatment, 12
had medication with oral antidiabetics whereas the
remaining six were on dietary control only.Cardiovascular risk factors
Smoking habits were assessed by means of a struc-
tured questionnaire, and the men were grouped into
current smokers, ex-smokers (those who had stopped
smoking and maintained cessation for more than 1
month prior to the examination) and never smokers.
The validity of smoking data was analysed by
comparison with blood concentrations of carbon
monoxide.16 Systolic and diastolic (phase V) blood
pressure was measured sphygmomanometrically with
the subject in the sitting position after 15 min of rest.
Blood pressure was recorded to the nearest 5 mmHg.
Hypertension was defined as systolic or diastolic
brachial blood pressureR160/95 mmHg or treatment
for hypertension.17 Blood cholesterol and triglyceride
levels were analysed by standard methods and
expressed in mmol/l. Body mass index (BMI) was
expressed as body weight (kg)/height2 (m2).Ankle–brachial blood pressure index (ABI) measurement
The recording system consisted of pulse sensors
(mercury-in-Silastic strain gauges) placed on the big
toes and thumbs; two Wheatstone bridges with
amplifier to record changes in the resistance of the
strain gauges; blood pressure cuffs (18!60 cm2 to
measure ankle systolic pressure and 12!35 cm2 to
measure the upper arm systolic pressure); a pressure
transducer (Siemens-Elema EMT 746 with amplifier
EMT 311) to record cuff pressures; and a six-channel
ink-jet recorder (Siemens-Elema; Mingograph).18,19
Duplicate recordings were made with the subject inthe supine position, and the arithmetic average used.
For each leg, an arm-ankle pressure index (ABI) was
calculated by dividing the ankle systolic pressure with
the highest upper arm systolic pressure value.
Definition of PAD
Peripheral arterial disease (PAD) at 68 years of age was
defined as an ABI!0.9 in one or both legs.6–8 Subjects
with an ABIR0.9 in both legs were considered free
from PAD. An ABIO1.3 was considered abnormally
high.20Mortality and morbidity surveillance
Mortality rate
All 474 participants in the 1982–1983 health examin-
ation were followed from this first examination until
their death or until December 31, 1996. Median (range)
follow-up time was 13.2 (0.3–14.3) years. The follow-
up analysis was based on a total of 5044 person years.
Mortality data were obtained by record linkage with
the Mortality Registry of the Swedish National Bureau
of Statistics. In 50% of the deaths, necropsy was
performed.
Mortality rates were expressed as deaths per 1000
person years of observation. Cases coded 390–448
according to the International Classification of Diseases
(ICD) code (8th revised version through 31 December
1986; 9th revised version since 1 January 1987) were
counted as deaths from cardiovascular disease.
Cardiac event rate
The follow-up period was from the 1982–1983 health
examination until the first cardiac event, death or
December 31, 1996. Median (range) follow-up time
was 12.0 (0.3–14.3) years, with a total follow up of 4717
person years. Cases with myocardial infarction were
retrieved by record linkage with the Malmo¨ Heart
Infarction Register.21 A cardiac event was defined as
fatal or nonfatal myocardial infarction (ICD-8 and
ICD-9: code 410.0–410.9) or death from ischaemic heart
disease (ICD-8 and ICD-9: code 410–414).Statistical methods
Distributions of ankle–brachial indices and cardiovas-
cular risk factors were expressed in terms of mean and
SD. ANOVA was used to compare distributions of
means and the chi-square test to evaluate differences
in proportions. Differences in blood triglyceride levels
were evaluated using the Kruskal–Wallis non-para-
metric test. Survival analysis, using the Kaplan–Meier
method with the generalised Wilcoxon rank sum test,Eur J Vasc Endovasc Surg Vol 29, February 2005
M. O¨gren et al.184and Cox’s proportional hazards model for multi-
variate analysis were used to study mortality and
cardiac event rate in relation to presence of diabetes
and PAD.ResultsAssessment of PAD in relation to diabetes in 68-year-old men
The prevalence of PAD was 29% (14 out of 48) in men
with diabetes (Table 1). Eight (17%) had bilateral
disease. Corresponding prevalences in men free from
diabetes were 12% (52 out of 426) (pZ0.003) and 4%
(16 out of 425) (pZ0.001), respectively. Nine men (2%)
had an ABI exceeding 1.3. Only one of them had
diabetes.Cardiovascular risk factors in relation to diabetes and PAD
Of the 48 men with diabetes, 42 (87.5%) were or had
been smokers. Of those having an abnormal pressure
index 36% were smokers (Table 2). Among those who
had diabetes and who had a normal pressure index
68% (23 out of 34) had quit smoking. Men with both
diabetes and PAD had the highest mean systolic blood
pressure and the highest prevalence of hypertension.
No major differences were found when comparing
plasma cholesterol, but diabetes was, as expected,
associated with higher levels of triglycerides (Table 2).Cardiac event and mortality rates in relation to diabetes
and PAD
Men who had diabetes and whose ABI was below 0.9
had a markedly higher cardiac event rate (102 events
per 1000 person years of follow up) when compared to
those with a normal pressure index (28 events/1000
person years; pZ0.005). The cardiac event rate in menTable 1. Distribution of ankle–brachial indices and prevalence of inte
age
Diabetes at 68 years of
age
N Intermittent
claudication at
68 years of age
Ankle–brachial i
N (%) Distribution of A
Best leg
Mean (95% CI)
No 426 16 (4%)* 1.08 (1.07–1.09)**
Yes 48 1 (2%)* 1.03 (0.99–1.08)**
Hyperglycemia only 28 0 (0%) 1.05 (1.00–1.11)
History of diabetes 20 1 (5%) 1.01 (0.91–1.11)
*pZ0.471, **pZ0.025, ***pZ0.003, †pZ0.001, ‡pZ0.731.
Eur J Vasc Endovasc Surg Vol 29, February 2005having neither diabetes nor PAD was 23 events/1000
person years (Table 3) (Fig. 1).
Diabetes was in the absence of PAD associated by
an increased rate of mortality (77 vs. 38 deaths per 1000
person years; p!0.001) (Table 3) (Fig. 2). This could
not entirely be accounted for by an increased
cardiovascular mortality rate (31 and 20 deaths/1000
person years, pZ0.065) (Table 3) (Fig. 3). Among those
with diabetes, presence of an abnormal ankle–brachial
index was not associated by any statistically signifi-
cant increase of the incidence of deaths.Multivariate analysis of cardiac event and mortality rates
In the multivariate analysis of the 14-year follow up,
PAD but not diabetes was associated by an increased
cardiac event rate (R.R. 1.8; 95% CI 1.1–3.0) when
entering smoking, hypertension, blood cholesterol and
BMI as covariates (Table 4). Diabetes and PAD were
both associated with an increased risk of death (R.R.
1.9; 95% CI 1.2–2.8 and R.R. 2.0; 95% CI 1.4–2.9).Discussion
The association between diabetes and peripheral
arterial disease has been addressed and established
in a number of cross-sectional and prospective studies.
Most of them have been based on the occurrence of
symptomatic disease, i.e. intermittent claudication or
severe limb ischaemia, in patients with insulin and
non-insulin dependent diabetes.22–25
In this study less than half of the men with diabetes
were aware of their condition, i.e. the diagnosis was
based on a fasting blood sugar level above 6.1 mmol/l.
Almost one third of those with diabetes had an ankle–
brachial index below 0.9 in the absence of symptoms of
PAD. Despite the apparently silent state of their
disease, two thirds of the men with diabetes as
compared with 47% of the healthy controls were normittent claudication and PAD in relation to diabetes at 68 years of
ndex (ABI) measurements at 68 years of age
BI Prevalence of
ABI!0.9
Prevalence of
ABIO1.3
Worst leg In either leg In both legs In either leg
Mean (95% CI) N (%) N (%) N (%)
1.01 (1.00–1.02)*** 52 (12%)*** 16 (4%)† 9 (2%)‡
0.95 (0.89–1.01)*** 14 (29%)*** 8 (17%)† 1 (2%)‡
0.97 (0.91–1.04) 7 (25%) 3 (11%) 0 (0%)
0.92 (0.81–1.02) 7 (35%) 5 (25%) 1 (5%)
Table 2. Cardiovascular risk factors in relation to diabetes and PAD at 68 years of age
Diabetes and PAD
at 68 years of age
N Cardiovascular risk factors at 68 years of age
Smoking habits Blood pressure (mmHg) Hyper-
tension
(%)†
Cholesterol
(mmol/l)
Triglycerides
(mmol/l)
Diabetes PAD Current Ex Never Systolic Diastolic
N (%)* N (%)* N (%)* Mean
(95% CI)**
Mean
(95% CI)***
Mean
(95% CI)‡
Mean
(95% CI)§
Yes Yes 14 5 (36%) 8 (57%) 1 (7%) 164
(153–176)
90
(85–96)
11/11
(100%)
6.5
(5.6–7.4)
3.14
(1.54–4.74)
Yes No 34 6 (18%) 23 (68%) 5 (15%) 158
(151–165)
96
(91–100)
27/32
(84%)
5.9
(5.4–6.3)
2.01
(1.47–2.54)
No Yes 52 20 (39%) 26 (50%) 6 (11%) 158
(152–164)
95
(92–98)
39/48
(81%)
6.1
(5.8–6.3)
1.61
(1.40–1.82)
No No 374 135 (36%) 163 (44%) 75 (20%) 152
(150–155)
92
(91–93)
206/347
(59%)
6.0
(5.9–6.1)
1.42
(1.36–1.48)
*pZ0.096, **pZ0.023, ***pZ0.068, †p!0.001, ‡p!0.297, §p!0.001.
Asymptomatic PAD in Diabetes 185longer alive at the end of follow up. Forty percent of
the diabetic men and 25% of the controls had
experienced a cardiac event.
Measurement of the ankle–brachial pressure index
is a simple and valid method for the detection of early,
non-symptomatic stages of atherosclerosis between
heart and ankle level.6–8 In studies on apparently
healthy subjects exposed to risk factors associated with
the occurrence of atherosclerotic disease the ankle–
brachial index can be used as a test to identify those
who are most vulnerable.26 It is our conclusion that theFig. 1. Cardiac event-free survival rate during 16-year follow u
presence of PAD and absence of diabetes (dotted line); (c) abs
presence of both PAD and diabetes (dashed-dotted line) at 68cardiovascular risk varies widely between diabetic
men with without PAD.
While blood flow impairment in PAD not associated
with diabetes is usually caused by lesions in the major
leg arteries, it is in many patients with diabetes caused
by obstructions in arteriolae and capillaries, i.e. small
vessel disease.27 Patients with isolated small vessel
disease have a normal ankle–brachial pressure index.
It remains to be evaluated whether these patients
similarly are exposed to an increased cardiovascular
risk. The absence of a significantly increasedp in the (a) absence of both diabetes and PAD (solid line); (b)
ence of PAD and presence of diabetes (dashed line); and (d)
years of age.
Eur J Vasc Endovasc Surg Vol 29, February 2005
T
a
b
le
3
.
C
a
rd
ia
c
e
v
e
n
t
ra
te
,
to
ta
l
a
n
d
ca
rd
io
v
a
sc
u
la
r
(C
V
)
m
o
rt
a
li
ty
ra
te
s
in
re
la
ti
o
n
to
d
ia
b
e
te
s
a
n
d
P
A
D
a
t
6
8
y
e
a
rs
o
f
a
g
e
D
ia
b
et
es
an
d
P
A
D
at
68
y
ea
rs
o
f
ag
e
N
C
ar
d
ia
c
ev
en
t
ra
te
M
o
rt
al
it
y
ra
te
s
D
ia
b
et
es
P
A
D
F
o
ll
o
w
u
p
(y
ea
rs
)
E
v
en
ts
E
v
en
ts
p
er
10
00
p
er
so
n
y
ea
rs
p-
v
al
u
e
F
o
ll
o
w
u
p
(y
ea
rs
)
A
ll
ca
u
se
m
o
rt
al
it
y
C
V
m
o
rt
al
it
y
D
ea
th
s
D
ea
th
s/
10
00
p
er
so
n
y
ea
rs
p
-v
al
u
e
D
ea
th
s
D
ea
th
s/
10
00
p
er
so
n
y
ea
rs
p-
v
al
u
e
N
%
N
%
N
%
Y
es
Y
es
14
98
.1
10
71
10
2.
0
!
0.
00
1
0.
02
6
0.
00
5
12
2.
1
10
71
81
.9
0.
01
1
0.
60
2
0.
59
1
7
50
57
.3
!
0.
00
1
0.
77
8
0.
18
3
Y
es
N
o
34
28
2.
2
8
24
28
.4
0.
46
9
0.
37
9
*
28
6.
6
22
65
76
.8
!
0.
00
1
0.
59
1
*
9
27
31
.4
0.
06
5
0.
14
1
*
N
o
Y
es
52
40
3.
2
16
31
39
.7
0.
01
8
*
42
3.
6
41
79
96
.8
!
0.
00
1
*;
25
48
59
.0
!
0.
00
1
*
N
o
N
o
37
4
39
33
.4
90
24
22
.9
*
42
11
.5
16
0
43
38
.0
*
83
22
19
.7
*
*
R
ef
er
en
ce
ca
te
g
o
ry
.
M. O¨gren et al.186
Eur J Vasc Endovasc Surg Vol 29, February 2005cardiovascular risk among men with diabetes whose
pressure index was above 0.9 should be viewed with
caution with regard to the likelihood of beta error, but
does not support this assumption.
Contrary to what might have been expected from
clinical studies of diabetes and PAD20 there were no
findings of clearly abnormally high ankle–brachial
indices indicative of medial sclerosis or calcification.
With respect to the association with diabetic neuro-
pathy one might consider the possibility of such
changes being more characteristic of later stage of
disease. Follow up studies indicate that these patients
are exposed to an increased risk of amputation.28
Whether diabetic neuropathy is a marker of an
increased risk of myocardial infarction and stroke
remains to be evaluated.
The cardiovascular risk and the magnitude of PAD
prevalence should be viewed against the high degree
of exposure to smoking and hypertension in this
cohort. This is unlikely to be a result of selection—85%
of the invited random sample of men born in 1914
participated in the study—but reflects the pattern of
exposure in this age cohort of men. In terms of risk
factor exposure, men with diabetes and low ankle–
brachial index deviated from those who had a normal
index in number of ways that could contribute to the
occurrence of PAD. The nature of the present study
does not allow any evaluation of relationship between
degree of glycaemic control and severity of leg artery
disease.
Some methodological issues need to be addressed.
Change in exposure is an inborn problem in long-term
cohort studies.29 We have no information on how
many of those with hyperglycemia developed symp-
toms of diabetes during the follow-up period. Neither
do we know to what extent patients with diabetes
were appropriately treated with regard to glycaemic
control. Participants without symptoms of leg artery
disease were not informed about the results from the
ankle–brachial pressure recording. The cut-off point
for plasma glucose indicating diabetes was at the time
of the baseline examination, i.e. 1982–1983, far above
6.1 mmol/l and very few of those with values above
6.1 mmol/l were therefore recommended to see their
physician for further evaluation of their blood glucose
level. The incidence of cardiovascular events is based
on record linkage with regional and national registers
with documented completeness and validity. None of
the participants was lost for follow up.
Almost one third of the men with diabetes in this
population based cohort had asymptomatic leg artery
disease. It is our conclusion from this study that a
blood glucose value above 6.1 mmol/l even in the
absence of symptoms indicating diabetes is associated
Fig. 2. Survival rate during 16-year follow up in the (a) absence of both diabetes and PAD (solid line); (b) presence of PAD and
absence of diabetes (dotted line); (c) absence of PAD and presence of diabetes (dashed line); and (d) presence of both PAD and
diabetes (dashed-dotted line) at 68 years of age.
Fig. 3. Cardiovascular death-free survival rate during 16-year follow up in the (a) absence of both diabetes and PAD (solid
line); (b) presence of PAD and absence of diabetes (dotted line); (c) absence of PAD and presence of diabetes (dashed line);
and (d) presence of both PAD and diabetes (dashed-dotted line) at 68 years of age.
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Table 4. Cox’ regression analysis of cardiac event rates and all cause mortality rates in relation to diabetes, PAD and risk factors for
atherosclerosis in 68-year-old men
Risk factor R.R. (95% CI)
Cardiac event
rate
All cause
mortality rate
Cardiovascular
mortality rate
Diabetes (Yes vs. no) 1.6 (0.9–2.9) 1.9 (1.2–2.8) 1.5 (0.8–2.8)
PAD (Yes vs. no) 1.8 (1.1–3.0) 2.0 (1.4–2.9) 2.3 (1.5–3.7)
Smoking (Ex vs. never) 1.7 (1.0–3.1) 1.4 (1.0–2.2) 1.7 (0.9–3.1)
(Current vs. never) 1.9 (1.0–3.5) 2.0 (1.3–3.0) 2.3 (1.2–4.2)
Hypertension (Yes vs. no) 1.5 (1.0–2.3) 1.7 (1.2–2.3) 2.1 (1.3–3.3)
Blood cholesterol (per mmol/l) 1.1 (0.9–1.4) 1.0 (0.8–1.1) 1.1 (0.9–1.3)
Body mass index (per kg/m2) 1.0 (1.0–1.1) 1.0 (0.9–1.0) 1.0 (1.0–1.1)
M. O¨gren et al.188by an increased prevalence of asymptomatic leg artery
disease and furthermore that cardiovascular vulner-
ability in diabetes patients can be assessed with
measurements of the systolic ankle–brachial pressure
index.Acknowledgements
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